SCHEMBL11269935

SCHEMBL11269935

C=CCn1cc2c(c1)CC(N(C)C)CC2

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.44
DRD1 P21728 1/20 0.44
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
HTR1A P08908 9/20 0.38
HTR7 P34969 9/20 0.38
CHRM3 P20309 2/20 0.37
HTR1D P28221 3/20 0.37
HTR1B P28222 3/20 0.37
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11273451 0.75 DRD2 (0.53) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL822940 0.64 HTR1A (0.61) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL823058 0.64 HTR1A (0.61) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL1950024 0.64 HTR1A (0.61) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL29507805 0.64 HTR1A (0.61) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL11493897 0.64 DRD2 (0.40) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL7410621 0.63 HTR6 (0.53) DRD2DRD4DRD3HTR1ACHRM3
Hydrochloric Acid SCHEMBL29064497 0.63 HTR1A (0.59) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL31564615 0.63 DRD2 (0.59) DRD2DRD1DRD4DRD3HTR1A
SCHEMBL11269661 0.61 SIGMAR1 (0.42) DRD2DRD1DRD4DRD3HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0014792-B1 TETRAHYDRO-2H-BENZO(C)PYRROLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE COMPOUNDS FOR USE AS THERAPEUTICALS ELI LILLY AND COMPANY (US) 1982-12-01 EP disclosed
US-4264622-A TREATMENT OF PARKINSON*S DISEASE ELI LILLY AND COMPANY (US) 1981-04-28 US disclosed
US-4235776-A USED FOR TREATMENT OF PARKINSON'S DISEASE, PROLACTIN INHIBITORS, AND DOPAMINE AGONISTS ELI LILLY AND COMPANY (US) 1980-11-25 US disclosed